Fusion with pep-1, a cell-penetrating peptide, enhances the transmembrane ability of human epidermal growth factor

References

• Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int. J. Cosmet. Sci. 2009;31:327–345.10.1111/ics.2009.31.issue-5
   PubMedGoogle Scholar
• Secchi G. Role of protein in cosmetics. Clin. Dermatol. 2008;26:321–325.10.1016/j.clindermatol.2008.04.004
   PubMed Web of Science ®Google Scholar
• Torin Huzil J, Sivaloganathan S, Kohandel M, et al. Drug delivery through the skin: molecular simulations of barrier lipids to design more effective noninvasive dermal and transdermal delivery systems for small molecules, biologics, and cosmetics. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2011;3:449–462.
   PubMed Web of Science ®Google Scholar
• Brown MB, Martin GP, Jones SA, et al. Dermal and transdermal drug delivery systems: current and future prospects. Drug Delivery. 2006;13:175–187.10.1080/10717540500455975
   PubMed Web of Science ®Google Scholar
• Ruan RQ, Wang SS, Wang CL, et al. Transdermal delivery of human epidermal growth factor facilitated by a peptide chaperon. Eur. J. Med. Chem. 2013;62:405–409.10.1016/j.ejmech.2012.12.054
   PubMed Web of Science ®Google Scholar
• Hardwicke J, Schmaljohann D, Boyce D, et al. Epidermal growth factor therapy and wound healing–past, present and future perspectives. Surgeon. 2008;6:172–177.10.1016/S1479-666X(08)80114-X
   PubMed Web of Science ®Google Scholar
• Herbst RS. Review of epidermal growth factor receptor biology. Int. J. Radiat. Oncol. Biol. Phys. 2004;59:S21–S26.10.1016/j.ijrobp.2003.11.041
   PubMed Web of Science ®Google Scholar
• Boonstra J, Rijken P, Humbel B, et al. The epidermal growth factor. Cell Biol. Int. 1995;19:413–430.10.1006/cbir.1995.1086
   PubMed Web of Science ®Google Scholar
• Jeon SO, Hwang HJ, Oh DH, et al. Enhanced percutaneous delivery of recombinant human epidermal growth factor employing nano-liposome system. J. Microencapsulation. 2012;29:234–241.10.3109/02652048.2011.646327
   PubMed Web of Science ®Google Scholar
• Duconge J, Prats PA, Valenzuela C, et al. Topical disposition of two strengths of a 125I-rhEGF jelly in rat skin wounds. Biopharm. Drug Dispos. 2004;25:193–201.10.1002/(ISSN)1099-081X
   PubMed Web of Science ®Google Scholar
• Patel LN, Zaro JL, Shen WC. Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm. Res. 2007;24:1977–1992.10.1007/s11095-007-9303-7
   PubMed Web of Science ®Google Scholar
• Zorko M, Langel U. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv. Drug Delivery Rev. 2005;57:529–545.10.1016/j.addr.2004.10.010
   PubMed Web of Science ®Google Scholar
• Jarver P. The use of cell-penetrating peptides as a tool for gene regulation. Drug Discovery Today. 2004;9:395–402.10.1016/S1359-6446(04)03042-9
   PubMed Web of Science ®Google Scholar
• Oehlke J, Scheller A, Wiesner B, et al. Cellular uptake of an α-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochimica et Biophysica Acta (BBA) – Biomembranes. 1998;1414:127–139.
   PubMed Web of Science ®Google Scholar
• Tara B, Wyman FN, Zelphati O, et al. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry. 1997;36:3008–3017.
   PubMed Web of Science ®Google Scholar
• Rittner K, Benavente A, Bompard-Sorlet A, et al. New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol. Ther. 2002;5:104–114.10.1006/mthe.2002.0523
   PubMed Web of Science ®Google Scholar
• Fernández-Carneado J, Kogan MJ, Castel S, et al. Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein. Angew. Chem. Int. Ed. Engl. 2004;43:1811–1814.10.1002/(ISSN)1521-3773
   PubMed Web of Science ®Google Scholar
• Morris MCVP, Chaloin L, Heitz F, et al. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res. 1997;25:2730–2736.10.1093/nar/25.14.2730
   PubMed Web of Science ®Google Scholar
• Morris MC, Depollier J, Mery J, et al. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 2001;19:1173–1176.10.1038/nbt1201-1173
   PubMed Web of Science ®Google Scholar
• Henriques ST, Castanho MA, Pattenden LK, et al. Fast membrane association is a crucial factor in the peptide pep-1 translocation mechanism: a kinetic study followed by surface plasmon resonance. Biopolymers. 2010;94:314–322.10.1002/bip.21367
   PubMed Web of Science ®Google Scholar
• Deshayes S, Morris M, Heitz F, et al. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv. Drug Delivery Rev. 2008;60:537–547.10.1016/j.addr.2007.09.005
   PubMed Web of Science ®Google Scholar
• Petrescu AD, Vespa A, Huang H, et al. Fluorescent sterols monitor cell penetrating peptide Pep-1 mediated uptake and intracellular targeting of cargo protein in living cells. Biochim. Biophys. Acta. 2009;1788:425–441.10.1016/j.bbamem.2008.09.015
   PubMed Web of Science ®Google Scholar
• Loudet A, Han J, Barhoumi R, et al. Non-covalent delivery of proteins into mammalian cells. Org. Biomol. Chem. 2008;6:4516–4522.10.1039/b809006h
   PubMed Web of Science ®Google Scholar
• Nasrollahi SA, Fouladdel S, Taghibiglou C, et al. A peptide carrier for the delivery of elastin into fibroblast cells. Int. J. Dermatol. 2012;51:923–929.
   PubMed Web of Science ®Google Scholar
• Zhang YE, Wang JN, Tang JM, et al. In vivo protein transduction: delivery of PEP-1-SOD1 fusion protein into myocardium efficiently protects against ischemic insult. Mol. Cells. 2009;27:159–166.10.1007/s10059-009-0020-4
   PubMed Web of Science ®Google Scholar
• Ahn EH, Kim DW, Shin MJ, et al. Fenobam promoted the neuroprotective effect of PEP-1-FK506BP following oxidative stress by increasing its transduction efficiency. BMB Rep. 2013;46:561–566.10.5483/BMBRep.2013.46.11.080
   PubMed Web of Science ®Google Scholar
• Gros E, Deshayes S, Morris MC, et al. A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction. Biochim. Biophys. Acta. 2006;1758:384–393.10.1016/j.bbamem.2006.02.006
   PubMed Web of Science ®Google Scholar
• Kim SY, Sohn EJ, Kim DW, et al. Transduced PEP-1-FK506BP ameliorates atopic dermatitis in NC/Nga mice. J. Invest. Dermatol. 2011;131:1477–1485.10.1038/jid.2011.49
   PubMed Web of Science ®Google Scholar
• Eum WS, Kim DW, Hwang IK, et al. In vivo protein transduction: biologically active intact pep-1-superoxide dismutase fusion protein efficiently protects against ischemic insult. Free Radical Biol. Med. 2004;37:1656–1669.
   PubMed Web of Science ®Google Scholar
• Kwon SW, Sohn EJ, Kim DW, et al. Anti-inflammatory effect of transduced PEP-1-heme oxygenase-1 in Raw 264.7 cells and a mouse edema model. Biochem. Biophys. Res. Commun. 2011;411:354–359.10.1016/j.bbrc.2011.06.147
   PubMed Web of Science ®Google Scholar
• Kim MJ, Jeong HJ, Kim DW, et al. PEP-1-PON1 protein regulates inflammatory response in raw 264.7 macrophages and ameliorates inflammation in a TPA-induced animal model. PLoS ONE. 2014;9:e86034.10.1371/journal.pone.0086034
   Google Scholar
• Ahn EH, Kim DW, Shin MJ, et al. PEP-1-PEA-15 protects against toxin-induced neuronal damage in a mouse model of Parkinson’s disease. Biochim. Biophys. Acta. 2014;1840:1686–1700.10.1016/j.bbagen.2014.01.004
   PubMed Web of Science ®Google Scholar
• Kim W, Kim DW, Yoo DY, et al. Neuroprotective effects of PEP-1-Cu,Zn-SOD against ischemic neuronal damage in the rabbit spinal cord. Neurochem. Res. 2012;37:307–313.10.1007/s11064-011-0613-0
   PubMed Web of Science ®Google Scholar
• Abdull Razis AF, Ismail EN, Hambali Z. Expression of recombinant human epidermal growth factor in Escherichia coli and characterization of its biological activity. Appl. Biochem. Biotechnol. 2007;144:249–261.
   Web of Science ®Google Scholar